Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04444453 · ClinicalTrials.gov registry record · NA

Early Ambulation to Reduce Hospital Length of Stay

A NA study, sponsored by University of Florida.

Completed
Registry status
NA
Development phase
38
Enrollment target

NCT04444453 is a NA study that has completed, run by University of Florida. The registered enrollment target is 38 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04444453, a NA study, has completed, sponsored by University of Florida.

COMPLETED
Registry status
NA
Development phase
38 participants
Enrollment target

Study Summary

Early ambulation of inpatients has been shown to be a key driver of decreased LOS and also reduced adverse events such as venous thromboembolism (VTE). We will test if a patient wearable device (pedometer) measuring steps and ambulation sessions decreases hospital LOS (primary outcome), decreases hospital LOS index (LOSI), decreases time to first ambulation, decreases time to first bowel movement (BM), decreases incidence of VTEs, and decreases costs (secondary outcomes). In a pilot randomized control trial, we will randomize 150 total adult patients admitted to UF Health Jacksonville in a 1:1 fashion to usual care and wearable pedometer or usual care. Patients randomized to the study intervention will receive a wearable pedometer upon admission, to be worn for the duration of their inpatient stay. Study outcome measures to be compared between the pedometer and no pedometer group include hospital LOS (primary outcome), hospital LOSI, time to first ambulation, time to first BM, incidence of VTEs, patient experience, and costs (secondary outcomes).

Interventions

  • DEVICE Wearable Pedometer

Trial Details

FieldValue
Enrollment Target 38 participants
Start Date 2020-10-21
Est. Completion 2022-09-01
Phase NA

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT04444453

The ClinicalTrials.gov registry entry for NCT04444453 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Wearable Pedometer is the first listed.

NCT04444453 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04444453 about?

NCT04444453 is a clinical study titled "Early Ambulation to Reduce Hospital Length of Stay". Early ambulation of inpatients has been shown to be a key driver of decreased LOS and also reduced adverse events such as venous thromboembolism (VTE). We will test if a patient wearable device (pedometer) measuring steps and ambulation sessions decreases hospital LOS (primary outcome), decreases ho...

What is the current status of trial NCT04444453?

This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2020-10-21. Estimated completion is 2022-09-01.

What interventions are being tested in trial NCT04444453?

The interventions under investigation include: Wearable Pedometer (DEVICE).

Who is sponsoring clinical trial NCT04444453?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.